• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Rampertab Shameze

    2/8/21 8:50:49 PM ET
    $TRXC
    Medical/Dental Instruments
    Health Care
    Get the next $TRXC alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    1. Name and Address of Reporting Person*
    Shameze Rampertab

    (Last) (First) (Middle)
    635 DAVIS DRIVE
    SUITE 300

    (Street)
    MORRISVILLE NC 27560

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    TRANSENTERIX, INC. [ TRXC ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    EVP, Chief Financial Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    02/08/2021
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Stock Options(1) $4.21 02/08/2021 A 73,078 (2) 02/08/2028 Common Stock 73,078 $0.00 73,078 D
    Restricted Stock Units(1)(3) $0.00 02/08/2021 A 59,112 (4) (4) Common Stock 59,112 $0.00 59,112 D
    Restricted Stock Units(1)(5) $0.00 02/08/2021 A 59,112 (6) (6) Common Stock 59,112 $0.00 59,112 D
    Restricted Stock Units(1)(3) $0.00 02/08/2021 A 59,200 (7) (7) Common Stock 59,200 $0.00 59,200 D
    Explanation of Responses:
    1. Award subject to forfeiture if the Registrant's stockholders do not approve an increase in the number of shares available under the Plan at the Registrant's 2021 annual meeting of stockholders.
    2. Vests one-third annually on each of February 4, 2022, 2023 and 2024, subject to acceleration as set forth in the Registrant's Amended and Restated Incentive Compensation Plan ("Plan") and the Reporting Person's Employment Agreement with the Registrant ("Employment Agreement").
    3. Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock.
    4. Forfeiture restrictions will lapse on the RSUs in three equal installments of 19,704 on each of February 4, 2022, 2023 and 2024, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Plan and the Employment Agreement.
    5. Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock.
    6. PRSU award with time-based vesting in three equal installments of 19,704 on each of February 4, 2022, 2023 and 2024, and performance-based vesting only if, designated corporate goals are met.
    7. Represents a discretionary retention bonus. Forfeiture restrictions will lapse on the RSUs on February 4, 2022, as long as the Reporting Person remains in continuous service during the vesting period.
    Remarks:
    /s/ Joshua Weingard, as attorney-in-fact for Shameze Rampertab 02/08/2021
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $TRXC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TRXC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $TRXC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Rampertab Shameze

    4 - TRANSENTERIX, INC. (0000876378) (Issuer)

    2/8/21 8:50:49 PM ET
    $TRXC
    Medical/Dental Instruments
    Health Care

    SEC Form 4: J. C. Anthony Fernando exercised 146,873 units of Common Stock at a strike of $0.00 and disposed of $214,521 worth of Common Stock (67,248 units at $3.19), increasing ownership by 143% to 135,126 units

    4 - TRANSENTERIX, INC. (0000876378) (Issuer)

    2/8/21 8:48:15 PM ET
    $TRXC
    Medical/Dental Instruments
    Health Care

    $TRXC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Asensus Surgical, Inc. Schedules Fourth Quarter and Fiscal Year 2020 Financial and Operating Results Conference Call for March 11, 2021

    RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release fourth quarter and fiscal year 2020 financial and operating results after the market closes on Thursday, March 11, 2021. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day. The call will be concurrently webcast. To listen to the conference call on your telephone, please dial 1-855-327-6837 for domestic callers and 1-631-891-4304

    3/4/21 6:55:00 AM ET
    $TRXC
    Medical/Dental Instruments
    Health Care

    Asensus Surgical Announces FDA Clearance in General Surgery

    RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: TRXC) , a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced the Company has received an additional FDA clearance for the Senhance Surgical System which allows for indication expansion in general surgery in the United States. Asensus Surgical's technology platform, Senhance® Surgical System, is the first of its kind digital laparoscopic platform that leverages augmented intelligence to provide unmatched performance and patient outcomes through machine learning.

    3/3/21 6:55:00 AM ET
    $TRXC
    Medical/Dental Instruments
    Health Care

    Asensus Surgical to Present at the H.C. Wainwright Virtual Global Life Sciences Conference

    RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery, announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the H.C. Wainwright Virtual Global Life Sciences Conference taking place March 9 and March 10, 2021. The Company’s presentation will be available for on-demand beginning Tuesday, March 9, 2021 at 7:00 am ET. The on-demand conference presentation wil

    3/1/21 6:55:00 AM ET
    $TRXC
    Medical/Dental Instruments
    Health Care

    $TRXC
    SEC Filings

    View All

    SEC Form 8-K filed

    8-K - ASENSUS SURGICAL, INC. (0000876378) (Filer)

    3/12/21 4:31:17 PM ET
    $TRXC
    Medical/Dental Instruments
    Health Care

    SEC Form 10-K filed

    10-K - ASENSUS SURGICAL, INC. (0000876378) (Filer)

    3/11/21 5:22:06 PM ET
    $TRXC
    Medical/Dental Instruments
    Health Care

    SEC Form 8-K filed

    8-K - ASENSUS SURGICAL, INC. (0000876378) (Filer)

    3/3/21 4:31:01 PM ET
    $TRXC
    Medical/Dental Instruments
    Health Care

    $TRXC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed

    SC 13G/A - TRANSENTERIX, INC. (0000876378) (Subject)

    2/16/21 9:51:05 AM ET
    $TRXC
    Medical/Dental Instruments
    Health Care